Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Septic Shock to Cardiovascular Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Septic Shock to Cardiovascular Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Septic Shock Therapeutics Clinical Trials 29 Prominent Drugs 31 Clinical Trial Profile Snapshots 32 Appendix 155 Abbreviations 155 Definitions 155 Research Methodology 156 Secondary Research 156 About GlobalData 157 Contact Us 157 Disclaimer 157 Source 158

List of Tables Septic Shock Therapeutics, Global, Clinical Trials by Region, 2016* 6 Septic Shock Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Septic Shock Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Septic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Septic Shock Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Septic Shock Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Septic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Septic Shock Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Septic Shock to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Septic Shock Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Septic Shock Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Septic Shock to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Septic Shock Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Septic Shock Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Septic Shock Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Septic Shock Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Septic Shock Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Septic Shock Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Septic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Septic Shock Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Septic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28 Septic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30 Septic Shock Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31 List of Figures Septic Shock Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Septic Shock Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Septic Shock Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Septic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Septic Shock Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Septic Shock Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Septic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Septic Shock Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Septic Shock to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Septic Shock Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Septic Shock Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Septic Shock to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Septic Shock Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Septic Shock Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Septic Shock Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Septic Shock Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Septic Shock Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Septic Shock Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Septic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Septic Shock Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Septic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Septic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Septic Shock Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31 GlobalData Methodology 156

Baxter International Inc. B. Braun Melsungen AG AstraZeneca Plc Parexel International Corporation Ferring International Center S.A. Eli Lilly and Company Eisai Co., Ltd. BTG Plc Bayer AG Abbott Laboratories